(1)
Hayashi, Y.; Tsukada, M.; Shinoda, D.; Matsui, M.; Iwama, K.; Kajiwara, K.; Kozai, Y. Combined Impact of Prior Polatuzumab Vedotin Plus Bendamustine and Rituximab Therapy and Myeloablative Conditioning on Early Post-Transplant BK Virus-Associated Hemorrhagic Cystitis. J Hematol 2025. https://doi.org/10.14740/jh2010.